InvestorsHub Logo
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

Re: None

Wednesday, 09/01/2021 4:42:31 PM

Wednesday, September 01, 2021 4:42:31 PM

Post# of 551

MyMD PHARMA'S PATHS TO SUCCESS

1. MyMD DEVELOPES WORLD'S 1ST 2nd GENERATION TNF-alpha MODULATOR.
2. LAB COMPARISONS OF MYMD-1 WITH 3 POPULAR JAK STAT BLOCKERS FINDS
IT TO BE EQUALLY EFFECTIVE, GIVING IT THE OPPORTUNITY TO GARNER
A PORTION OF THIS MARKET.
3. MyMD EXPECTS TO OFFER ALL HUMANS OVER THE AGE OF 64 THE OPPORTUNITY
TO LIVE LONGER, AND HEALTHIER WHILE DOING SO. IT ALSO SEES THE SAME
BENEFIT TO ALL OTHER MAMMALS WHO REACH COMPARABLE AGES.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News